These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 39490314)

  • 21. Cardiac and Stress Biomarkers and Chronic Kidney Disease Progression: The CRIC Study.
    Bansal N; Zelnick L; Shlipak MG; Anderson A; Christenson R; Deo R; deFilippi C; Feldman H; Lash J; He J; Kusek J; Ky B; Seliger S; Soliman EZ; Go AS;
    Clin Chem; 2019 Nov; 65(11):1448-1457. PubMed ID: 31578216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating α-klotho levels in CKD and relationship to progression.
    Kim HR; Nam BY; Kim DW; Kang MW; Han JH; Lee MJ; Shin DH; Doh FM; Koo HM; Ko KI; Kim CH; Oh HJ; Yoo TH; Kang SW; Han DS; Han SH
    Am J Kidney Dis; 2013 Jun; 61(6):899-909. PubMed ID: 23540260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of fractional phosphate excretion on the relation of FGF23 with outcome in CKD patients.
    Bech AP; Bouma-de Krijger A; van Zuilen AD; Bots ML; van den Brand JA; Blankestijn PJ; Wetzels JF; Vervloet MG
    J Nephrol; 2015 Aug; 28(4):477-84. PubMed ID: 25700931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Klotho and Clinical Outcomes in CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Edmonston D; Fuchs MAA; Burke EJ; Isakova T; Wolf M;
    Am J Kidney Dis; 2024 Sep; 84(3):349-360.e1. PubMed ID: 38583756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Educational level and risk of chronic kidney disease: longitudinal data from the PREVEND study.
    Thio CHL; Vart P; Kieneker LM; Snieder H; Gansevoort RT; Bültmann U
    Nephrol Dial Transplant; 2020 Jul; 35(7):1211-1218. PubMed ID: 30541108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma Homocysteine Is a Predictive Factor for Accelerated Renal Function Decline and Chronic Kidney Disease in a Community-Dwelling Population.
    Xiao W; Ye P; Wang F; Cao R; Bai Y; Wang X
    Kidney Blood Press Res; 2021; 46(5):541-549. PubMed ID: 34365457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sex and the Risk of Atheromatous and Nonatheromatous Cardiovascular Disease in CKD: Findings From the CKD-REIN Cohort Study.
    Faucon AL; Lambert O; Massy Z; Drüeke TB; Combe C; Fouque D; Frimat L; Jacquelinet C; Laville M; Liabeuf S; Pecoits-Filho R; Hauguel-Moreau M; Mansencal N; Alencar de Pinho N; Stengel B;
    Am J Kidney Dis; 2024 Nov; 84(5):546-556.e1. PubMed ID: 38925506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum peroxiredoxin-4, a biomarker of oxidative stress, is associated with the development of nephropathy in patients with type 2 diabetes (Zodiac-65).
    Bourgonje AR; van Goor H; Bakker SJL; Hillebrands JL; Bilo HJG; Dullaart RPF; van Dijk PR
    Free Radic Biol Med; 2024 Feb; 212():186-190. PubMed ID: 38151214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibroblast growth factor 23 and incident CKD in type 2 diabetes.
    Isakova T; Craven TE; Lee J; Scialla JJ; Xie H; Wahl P; Marcovina SM; Byington RP; Wolf M
    Clin J Am Soc Nephrol; 2015 Jan; 10(1):29-38. PubMed ID: 25343949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimated Glomerular Filtration Rate and Albuminuria Are Associated with Biomarkers of Cardiac Injury in a Population-Based Cohort Study: The Maastricht Study.
    Martens RJ; Kimenai DM; Kooman JP; Stehouwer CD; Tan FE; Bekers O; Dagnelie PC; van der Kallen CJ; Kroon AA; Leunissen KM; van der Sande FM; Schaper NC; Sep SJ; Schram MT; van Suijlen JD; van Dieijen-Visser MP; Meex SJ; Henry RM
    Clin Chem; 2017 Apr; 63(4):887-897. PubMed ID: 28213568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low potassium excretion but not high sodium excretion is associated with increased risk of developing chronic kidney disease.
    Kieneker LM; Bakker SJ; de Boer RA; Navis GJ; Gansevoort RT; Joosten MM
    Kidney Int; 2016 Oct; 90(4):888-96. PubMed ID: 27575557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoluminometric assay for quantification of peroxiredoxin 4 in human serum.
    Schulte J; Struck J; Bergmann A; Köhrle J
    Clin Chim Acta; 2010 Sep; 411(17-18):1258-63. PubMed ID: 20493180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of NGAL in early stage chronic kidney disease.
    Basturk T; Sari O; Koc Y; Eren N; Isleem M; Kara E; Sevinc M; Sakaci T; Ahbap E; Hasbal NB; Bayrakdar Caglayan F; Unsal A
    Minerva Urol Nefrol; 2017 Jun; 69(3):307-312. PubMed ID: 27768023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Associations of Urine and Plasma Metabolites With Kidney Failure and Death in a Chronic Kidney Disease Cohort.
    Steinbrenner I; Schultheiss UT; Bächle H; Cheng Y; Behning C; Schmid M; Yeo WJ; Yu B; Grams ME; Schlosser P; Stockmann H; Gronwald W; Oefner PJ; Schaeffner E; Eckardt KU; Köttgen A; Sekula P;
    Am J Kidney Dis; 2024 Oct; 84(4):469-481. PubMed ID: 38815646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood Pressure, Incident Cognitive Impairment, and Severity of CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Babroudi S; Tighiouart H; Schrauben SJ; Cohen JB; Fischer MJ; Rahman M; Hsu CY; Sozio SM; Weir M; Sarnak M; Yaffe K; Tamura MK; Drew D;
    Am J Kidney Dis; 2023 Oct; 82(4):443-453.e1. PubMed ID: 37245689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical prediction models for progression of chronic kidney disease to end-stage kidney failure under pre-dialysis nephrology care: results from the Chronic Kidney Disease Japan Cohort Study.
    Hasegawa T; Sakamaki K; Koiwa F; Akizawa T; Hishida A;
    Clin Exp Nephrol; 2019 Feb; 23(2):189-198. PubMed ID: 30069609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    Koye DN; Magliano DJ; Reid CM; Jepson C; Feldman HI; Herman WH; Shaw JE
    Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Familial Aggregation of CKD and Heritability of Kidney Biomarkers in the General Population: The Lifelines Cohort Study.
    Zhang J; Thio CHL; Gansevoort RT; Snieder H
    Am J Kidney Dis; 2021 Jun; 77(6):869-878. PubMed ID: 33359149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated serum anion gap in adults with moderate chronic kidney disease increases risk for progression to end-stage renal disease.
    Banerjee T; Crews DC; Wesson DE; McCulloch CE; Johansen KL; Saydah S; Rios Burrows N; Saran R; Gillespie B; Bragg-Gresham J; Powe NR
    Am J Physiol Renal Physiol; 2019 Jun; 316(6):F1244-F1253. PubMed ID: 30908932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proenkephalin and risk of developing chronic kidney disease: the Prevention of Renal and Vascular End-stage Disease study.
    Kieneker LM; Hartmann O; Bergmann A; de Boer RA; Gansevoort RT; Joosten MM; Struck J; Bakker SJL
    Biomarkers; 2018 Jul; 23(5):474-482. PubMed ID: 29466891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.